PCI Pharma Services Completes Biotech CoE

PCI Pharma Services (PCI) has completed the expansion of its new Biotech Center of Excellence in Philadelphia, PA. PCI is also investing to expand its global packaging capabilities at its operations in Ireland that will provide global packaging services for biologics and injectable drug products.

The recent investments include partnerships with suppliers such as Dividella, groninger, Marchesini Group and Syntegon (formerly Bosch Packaging Technology) to provide state-of-the-art equipment for pre-filled syringe, auto-injector and vial packaging and the latest serialization technology. The expansions also include increasing high-speed automatic syringe assembly and labeling, vial labeling and cartoning, and auto-injector assembly. In addition to building out existing cold storage capabilities and leading-edge manufacturing suites, PCI will continue to offer innovative design teams to help address the packaging challenges often presented by biologic products.

“Worldwide forecasts for biologics show strong growth over the next several years, and PCI is staying on top of this trend and investing in the latest technology to enhance capacity and accommodate the novel drug delivery formats of biologic products. We have already secured projects from numerous global biopharmaceutical customers that will benefit from the new expansion, which is a reflection of market demand,” said Salim Haffar, chief executive officer, PCI Pharma Services. “PCI has a rich heritage in biologics going back more than 20 years, but we now have the opportunity to apply this expertise on a larger scale. We are looking forward to leveraging our breadth of experience with the latest technology to help our customers bring life-changing therapies to patients.”